Casein kinase II
Phosphorylation of clock proteins represents an important mechanism regulating circadian clocks. In Neurospora, clock protein
FREQUENCY (FRQ) is progressively phosphorylated over time, and its level decreases when it is extensively phosphorylated. To
identify the kinase phosphorylating FRQ and to understand the function of FRQ phosphorylation, a FRQ-phosphorylating kinase was
purified and identified as casein kinase II (CKII). Disruption of the catalytic subunit gene of CKII in Neurospora results in
hypophosphorylation and increased levels of FRQ protein. In addition, the circadian rhythms of frq RNA, FRQ protein, and
clock-controlled genes are abolished in the CKII mutant. These data suggest that the phosphorylation of FRQ by CKII may have at least three functions; it decreases
the stability of FRQ, reduces the protein complex formation between FRQ and the WHITE COLLAR proteins, and is important for the closing of the Neurospora
circadian negative feedback loop. Taken together, these results suggest that CKII is an important component of the Neurospora circadian clock (Yang, 2002).
CKII (CK2) is also involved in the function of the Arabidopsis
circadian clock. In vitro, CKII subunits of
Arabidopsis have been shown to interact and phosphorylate the
circadian clock-associated 1 (CCA1) protein. The phosphorylation of
CCA1 by CKII-like activity in vitro affects the formation of a
DNA-protein complex containing CCA1. In addition, overexpression of a
regulatory subunit of CKII results in the shortening of the periods of
clock-controlled genes in Arabidopsis. Because the
Neurospora WC complex binds to DNA and FRQ interacts with the
WCs, it is possible that the CKII phosphorylation of FRQ influences the
formation of the DNA-WC complex (Yang, 2002).
In Drosophila, the phosphorylation of Tim appears to have at
least two different functions. The phosphorylation of Tim by Sgg
promotes the nuclear transfer of the Per/Tim complex, whereas a tyrosine-linked phosphorylation of Tim by an unknown
kinase is implicated in the proteasome-mediated degradation of Tim. Dbt of Drosophila and the casein kinase
Iepsilon in mammals phosphorylate Per and may trigger its turnover. Although both CKI and CKII are Ser/Thr kinases, their structures and substrate
specificities are significantly different, suggesting that they did not
evolve from a common ancestral protein (Yang, 2002).
Unlike Dbt and Sgg in Drosophila and CKII in Saccharomyces, both of which are required for the survival of their respective organisms, CKII
of Neurospora is not essential for the survival of
Neurospora. However, the Neurospora CKII is important
for the normal growth and development of the fungus. As a protein
serine/threonine kinase that is ubiquitously found in eukaryotes, CKII
is known to phosphorylate many substrates and regulate many processes
in eukaryotic cells. However, in Neurospora, it is thought that the clock defects in the ckaRIP mutant are probably not caused by its
growth and developmental defects. (1) In genetic screening for clock
mutants, it has been found that most of Neurospora growth and
developmental mutants have normal functional clocks. (2) It was well known that the growth rate of Neurospora
is not an influencing factor in the function of the clock. (3) The molecular phenotypes of CKII are very similar
to those of the frq null strain. These results suggest
that the loss of clock function in the cka mutant appears to
be the result of loss of the fully functional FRQ protein. (4) In
this study, CKII was identified as a potential clock component due to
its role of phosphorylating FRQ, one of the central components of the
Neurospora clock, in vitro and in vivo. Based on these data,
it is thought that the role of CKII in the Neurospora circadian oscillator may be unrelated to its function in cell growth and development. However, the possibility that the growth and developmental defects indirectly contributed to the clock phenotypes observed in the ckaRIP strains cannot be ruled out. It is also not known whether CKII can affect the clock by regulating the activity of other unknown clock genes in Neurospora (Yang, 2002).
The eukaryotic circadian oscillators consist of circadian negative feedback loops. In Neurospora, it was proposed that the FREQUENCY (FRQ) protein promotes the phosphorylation of the WHITE COLLAR (WC) complex, thus inhibiting its activity. The kinase(s) involved in this process is not known. This study shows that the disruption of the interaction between FRQ and CK-1a (a casein kinase I homolog) results in the hypophosphorylation of FRQ, WC-1, and WC-2. In the ck-1aL strain, a knock-in mutant that carries a mutation equivalent to that of the Drosophila dbtL mutation, FRQ, WC-1, and WC-2 are hypophosphorylated. The mutant also exhibits ~32 h circadian rhythms due to the increase of FRQ stability and the significant delay of FRQ progressive phosphorylation. In addition, the levels of WC-1 and WC-2 are low in the ck-1aL strain, indicating that CK-1a is also important for the circadian positive feedback loops. In spite of its low accumulation in the ck-1aL strain, the hypophosphorylated WCC efficiently binds to the C-box within the frq promoter, presumably because it cannot be inactivated through FRQ-mediated phosphorylation. Furthermore, WC-1 and WC-2 are also hypophosphorylated in the ckaRIP strain, which carries the disruption of the catalytic subunit of casein kinase II. In the ckaRIP strain, WCC binding to the C-box is constantly high and cannot be inhibited by FRQ despite high FRQ levels, resulting in high levels of frq RNA. Together, these results suggest that CKI and CKII, in addition to being the FRQ kinases, mediate the FRQ-dependent phosphorylation of WCs, which inhibit their activity and close the circadian negative feedback loop (He, 2006).
The eukaryotic circadian clocks are composed of auto- regulatory circadian negative feedback loops including both positive and negative elements. In Neurospora, Drosophila, and mammals, the positive elements are all heterodimeric complexes, consisting of two PER-ARNT-SIM (PAS) domain-containing transcriptional factors that bind to the cis-elements in the promoter of the negative elements to activate their transcription. In contrast, the negative elements repress their own transcription by inhibiting the activity of the positive elements through their physical interactions. It is unclear how negative elements inhibit the activity of positive elements to close the circadian negative feedback loops. Since the identification of the Drosophila doubletime (dbt) gene, which encodes for a casein kinase I (CKI) homolog, it has become clear that post-translational protein phosphorylation is essential for the function of circadian clocks. Despite the evolutionary distance, remarkable conservation of post-translational regulation exists among different eukaryotic systems from fungi to human (He, 2006).
In the filamentous fungus Neurospora crassa, the core circadian negative feedback loop consists of four essential components: WHITE COLLAR-1 (WC-1), WC-2, FREQUENCY (FRQ), and a FRQ-interacting RNA hecliase FRH. WC-1 and WC-2, two PAS domain-containing transcription factors, form a heterodimeric WC complex (D-WCC) in the dark, which binds to the Clock (C)-box in the frq promoter to activate frq transcription. Thus, WCC is the positive element in the Neurospora circadian negative feedback loop. In contrast, FFC, the complex formed by FRQ and FRH functions as the negative element. To repress the transcription of frq, FFC possibly mediates the inhibition of the WCC activity through their physical interaction. In a wild-type strain, this circadian negative feedback loop generates robust daily rhythms of frq RNA and FRQ protein. When the circadian negative feedback loop is disrupted by mutation of frq or down-regulation of frh, frq RNA levels stay at constant higher levels, resulting in arrhythmici- ties. In addition to their role in the circadian negative feedback loop in the dark, WC-1and WC-2 are also essential components for the light responses and light resetting of the clock, with WC-1 being the blue-light photoreceptor (He, 2006).
In addition to the repression of D-WCC activity in the dark, FRQ promotes the accumulation of WC-1 and WC-2, forming positive feedback loops that are inter-locked with the negative loop, a feature that is shared by animal circadian systems. In Neurospora, these positive feedback loops have been shown to be important for the robustness and function of the clock. It was recently shown that the phosphorylation of the PEST-2 region of cytoplasmic FRQ is important for the accumulation of WC-1 but not WC-2 (He, 2006).
FRQ, WC-1, and WC-2 are regulated by phosphorylation events. After its synthesis, FRQ is immediately phosphorylated and becomes progressively more phosphorylated over time before its degradation through the ubiquitinproteasome pathway mediated by FWD-1. Thus, in the dark, FRQ is not only robustly rhythmic in quantity, but also in its phosphorylation states. CK-1a (casein kinase 1a), CKII (casein kinase II), and CAMK-1 are the three identified FRQ kinases. However, only CKII's role in mediating FRQ phosphorylation is firmly established in vivo. In vitro, CKII is one of the main kinases that phosphorylate FRQ. In strains in which either the CKII catalytic subunit (cka) or one of its regulatory subunits (ckb1) is disrupted, FRQ is both hypophosphorylated and more stable, and the clock function is either completely abolished (cka mutant) or oscillates with a severely damped amplitude (ckb1 mutant). Furthermore, in the cka mutant strain that has no CKII activity, frq mRNA levels are constantly high, which is reminiscent of the frq RNA levels in strains with a disrupted circadian negative feedback loop. These data suggest that CKII not only promotes FRQ degradation, but it is also required for the repressor function of FRQ. The mechanism by which CKII carries this latter function is not known (He, 2006).
CK-1a is one of the two Neurospora CKI homologs and it can phosphorylate the PEST-1 and PEST-2 domains of FRQ in vitro. The deletion of the PEST-1 domain resulted in the increased stability of FRQ and a long period rhythm. More importantly, CK-1a was found to associate with FRQ, suggesting that it may phosphorylate FRQ in vivo. However, in vivo evidence for the involvement of CK-1a in the clock was not available because CK-1a is essential for cell survival in Neurospora (He, 2006).
Similar to FRQ, both WC-1 and WC-2 are phosphorylated both in the dark and in a light-dependent manner. Their phosphorylation plays important roles in regulating WCC activity. Five major in vivo WC-1 phosphorylation sites, located immediately downstream from its DNA-binding domain, have been identified. Mutation of these light-independent sites suggested that they are critical for circadian clock function and they negatively regulate the D-WCC activity. The importance of WC phosphorylation in the circadian clock was later confirmed by the surprising observation that the WC phosphorylation is FRQ dependent. In the frq-null strain, both WC-1 and WC-2 are hypophosphorylated. In a wild- type strain, WC-2 exhibits a robust circadian rhythm of its phosphorylation profile when analyzed on two-dimensional electrophoresis. Importantly, the activation of frq transcription correlates with the hypophosphorylation of the WCs. Consistent with these data, it has been shown that dephosphorylation of the Neurospora WCC significantly promotes its binding to the C-box. Together, these results suggest a model in which FFC inhibits the WCC activity by promoting the phosphorylation of WC proteins. Interestingly, PER-dependent phosphorylation of CLK has also been observed in Drosophila, suggesting a common mechanism that closes the circadian negative feedback loops (He, 2006).
The kinase(s) recruited by FRQ to phosphorylate the WC proteins has not been identified. How WCC activity is affected by the phosphorylation mediated by this kinase(s) is also not known. In this study, it is shown that like CKII, CK-1a phosphorylates FRQ in vivo to promote its degradation. More importantly, both kinases mediate the FRQ-dependent phosphorylation of WCC, which inhibits its activity to close the circadian negative feedback loop. In addition to CK-1a's role in the negative feedback loop, it is also required for the function of the circadian positive feedback loops by increasing WC levels (He, 2006).
Regulation of circadian clock components by phosphorylation plays essential roles in clock functions and is conserved from fungi to mammals. In the Neurospora circadian negative feedback loop, FREQUENCY (FRQ) protein inhibits WHITE COLLAR (WC) complex activity by recruiting the casein kinases CKI and CKII to phosphorylate the WC proteins, resulting in the repression of frq transcription. In contrast, CKI and CKII progressively phosphorylate FRQ to promote FRQ degradation, a process that is a major determinant of circadian period length. By using whole-cell isotope labeling and quantitative mass spectrometry methods, this study shows that the WC-1 phosphorylation events critical for the negative feedback process occur sequentially-first by a priming kinase, then by the FRQ-recruited casein kinases. The cyclic AMP-dependent protein kinase A (PKA) is essential for clock function and inhibits WC activity by serving as a priming kinase for the casein kinases. In addition, PKA also regulates FRQ phosphorylation, but unlike CKI and CKII, PKA stabilizes FRQ, similar to the stabilization of human PERIOD2 (hPER2) due to the phosphorylation at the familial advanced sleep phase syndrome (FASPS) site. Thus, PKA is a key clock component that regulates several critical processes in the circadian negative feedback loop (Huang, 2007).
The highly conserved protein kinase casein kinase II (CKII) is required for efficient Pol III transcription of the tRNA and 5S rRNA genes in Saccharomyces cerevisiae. TFIIIB is the CKII-responsive component of the Pol III transcription machinery. Dephosphorylation of TFIIIB eliminates its ability to complement CKII-depleted extract, and a single TFIIIB subunit, the TATA-binding protein (TBP), is a preferred substrate of CKII in vitro. Recombinant TBP purified from Escherichia coli is phosphorylated efficiently by CKII and, in the presence of a limiting amount of CKII, is able to substantially rescue transcription in CKII-deficient extract. These results establish that TBP is a key component of the pathway linking CKII activity and Pol III transcription and suggest that TBP is the target of a CKII-mediated regulatory mechanism that can modulate Pol III transcription (Ghavidel, 1997).
Complementary DNAs encoding the beta subunit of Casein kinase II (CkII beta) from the nematode
Caenorhabditis elegans were cloned and sequenced. The predicted beta subunit polypeptide comprises
234 amino acid residues and has a Mr of 26,452. CkII beta is not homologous with other types of
proteins. In synchronously developing C. elegans the abundance of the 1.3-kilobase mRNA for CkII
beta varies in parallel with the level of mRNA encoding the catalytic subunit (alpha) of CkII. Thus, the
developmental expression of CkII subunits is controlled coordinately and pretranslationally. CkII beta
and CkII alpha mRNAs are enriched 5-10-fold in C. elegans embryos relative to their concentrations
at several other stages of nematode development. A 3.8-kilobase pair segment of C. elegans DNA that
contains the CkII beta gene and an extensive 5'-flanking region was cloned and sequenced. The CkII
beta gene is divided into 6 exons by introns ranging from 49 to 533 base pairs in length. The first exon
encodes 88 nucleotides of 5'-untranslated mRNA. Exon 2 (72 base pairs) contains the initiator Met
codon and only 5 additional codons. Exons 3-6 encode 52, 63, 64, and 49 amino acid residues,
respectively. The 5' terminus of CkII beta mRNA is modified post-transcriptionally by trans-splicing
with a leader sequence of 22 nucleotides. The CkII beta gene maps to a position on C. elegans
chromosome 2 that is in close proximity to the lin-11 gene (Hu, 1991).
cDNA clones coding for the alpha and beta subunits of CK2 in zebrafish (Danio
rerio) have been isolated. One contains the
complete coding sequence for the beta subunit of CK2 while the alpha clone is truncated and lacks 183
nucleotides of the 5' coding region. Comparison of the deduced amino acid sequences shows an
extremely high degree of evolutionary sequence conservation for these two proteins. Northern analysis
of the mRNAs coding for the alpha subunit indicates that this messenger is present in 1 h embryos as a
3.6 Kb and a 1.9 Kb species, both of which decrease in 24-h embryos. In the case of beta, the major
mRNA species of approximately 1.7 Kb maintained its level during the period of embryogenesis studied.
In situ hybridization of early embryos, using antisense RNAs against alpha and beta mRNAs
demonstrates temporal and tissue specific expression patterns. The alpha mRNA decreases after
blastula, when it is evenly distributed. The beta mRNA is maintained at high levels between 4 and 24 h
of development, showing in 18 h embryos a higher concentration in the developing neural tube and in
the embryonic optic and otic vesicles (Daniotti, 1994).
In
Xenopus oocytes, CKIIbeta, associates with both CKIIalpha and the serine/threonine kinase, Mos. As a key
regulator of meiosis, Mos is necessary and sufficient to initiate oocyte maturation. The binding of CKIIbeta to Mos represses Mos-mediated mitogen-activated protein kinase
(MAPK) activation; the ectopic expression of CKIIbeta inhibits progesterone-induced Xenopus
oocyte maturation. Oocytes with a reduced
content of CKIIbeta (achieved by using antisense oligonucleotide to CKIIbeta) are more sensitive to low doses of progesterone and show accelerated MAPK
activation and germinal vesicle breakdown. Ectopic expression of a Mos-binding fragment
of CKIIbeta suppresses the effect of antisense oligonucleotide. These results suggest that the
endogenous CKIIbeta normally sets a threshold level for Mos protein, which must be exceeded for
Mos to activate the MAPK signaling pathway and induce oocyte maturation (Chen, 1997).
The expression and distribution of Casein kinase 2 subunits in mouse embryos at different developmental stages was investigated: expression at the mRNA level of CK2 alpha- and beta-subunits (by in situ hybridization) and distribution at the protein level by immunohistochemistry using CK2-alpha-antibodies (expression) and CK2-beta-specific antibodies (distribution). In general both methods gave similar results. In earlier stages of mouse embryonic development (day 10.5 after coitus) CK2 is expressed at a higher level in neuroepithelia than in all other tissues. From day 11.5 on, high expression of CK2 is detected in all epithelia. From day 16.5 on, all tissues and anlagen of the fetus involved in organogenesis reveal a higher CK2 expression as compared with secondary mesenchyma. The only difference between in situ hybridization and immunocytochemistry is observed in the skin. Transcripts of CK2 are found mostly in the basal layer of the epidermis and in the nuclei of keratinocytes, whereas CK2 protein is almost exclusively found in the cytoplasm of epidermal cells (Mestres, 1994).
Protein kinase CK2 is very abundant in rat brain when compared with other rat tissues. The enzyme is
an oligomeric protein with the structures three possible heterotrimeric structures: alpha2 beta2, alpha alpha'beta2 and alpha'2 beta2. The
alpha and alpha' subunits are catalytic and have a high degree of homology, whereas the beta subunit
seems regulatory. There is a significant increase in the amount of
alpha' subunit during the late postnatal neocortical maturation period. The increased alpha' expression
occurs at a time parallel to synaptogenesis. As for its distribution, the alpha' subunit of CK2 is much
more abundant in neurons (particularly in large size neurons) than it is in glia. These results are
consistent with a hypothetical role for CK2 isoforms containing alpha' subunits in the regulation of
specific functions in fully differentiated neurons (Diaz-Nido, 1994).
The activity and cellular localization of hepatic Casein kinase II (CkII) was examined during late fetal development in the rat. Cultured fetal hepatocytes display constitutive CKII activity that is not further activated by growth factor exposure. Similarly, fetal liver CKII shows approximately fivefold greater activity than adult liver. The fetal hepatic activity is, to a large degree, localized to a nuclear fraction. Postnuclear cytosol preparations from fetal and adult liver show similar CKII activity. Immunoreactive CKII coincides with kinase activity. However, a higher (five- to sixfold) CKII specific activity is found in nuclear extracts compared to cytosol. In summary, fetal hepatic CKII demonstrates coincident nuclear localization and activation. It is hypothesized that the regulation of hepatic CKII is relevant to the mitogen-independent proliferation displayed by fetal rat hepatocytes (Gruppuso, 1995).
A wide range of processes in plants, including expression of certain genes, is regulated by endogenous circadian rhythms. The circadian clock-associated 1 (CCA1) and the late elongated hypocotyl (LHY) proteins have been shown to be closely associated with clock function in Arabidopsis thaliana. The protein kinase CK2 can interact with and phosphorylate CCA1, but its role in the regulation of the circadian clock has remained unknown. This study shows that plants overexpressing CKB3, a regulatory subunit of CK2, display increased CK2 activity and shorter periods of rhythmic expression of CCA1 and LHY. CK2 is also able to interact with and phosphorylate LHY in vitro. Additionally, overexpression of CKB3 shortens the periods of four known circadian clock-controlled genes with different phase angles, demonstrating that many clock outputs are affected. This overexpression also reduces phytochrome induction of an Lhcb gene. Finally, the photoperiodic flowering response, which is influenced by circadian rhythms, is diminished in the transgenic lines, and the plants flower earlier on both long-day and short-day photoperiods. These data demonstrate that CK2 is involved in regulation of the circadian clock in Arabidopsis (Sugano, 1999).
In a search for protein kinase CK2 beta subunit binding proteins using the two-hybrid system, more than 1000 positive clones were isolated. Beside clones for the alpha' and beta subunit of CK2, there were clones coding for a so far unknown protein, whose partial cDNA sequence was already deposited in the EMBL database under the accession numbers R08806 and Z17360, for the ribosomal protein L5 and for A-Raf kinase. All isolated clones except the one for CK2 beta show no interaction with the catalytic alpha subunit of CK2. A-Raf kinase is a new interesting partner of CK2 beta. The isolated A-Raf clone represents amino acids 268-606, but also a full length A-Raf clone interacts with CK2 beta. At the site of CK2 beta, residue 175 and amino acids between residues 194 and 200 are likely to be involved in direct interaction (Boldyreff, 1996).
Two protein kinases that are involved in proliferation and oncogenesis but so far have been thought to be
functionally independent are Raf and CK2. The Raf signaling pathway is known to play a critical role
in such fundamental biological processes as cellular proliferation and differentiation. Abnormal
activation of this pathway is potentially oncogenic. Protein kinase CK2 exhibits enhanced levels in solid
human tumors and proliferating tissue. In a two-hybrid screen of a mouse-embryo cDNA library an interaction between A-Raf and CK2beta subunit has been detected. This binding is specific, as no
interaction between CK2beta and B-Raf or c-Raf-1 is observed. Regions critical for this interaction
are located between residues 550 and 569 in the A-Raf kinase domain. A-Raf kinase activity is
enhanced 10-fold upon coexpression with CK2beta in Sf9 cells. The alpha subunit of CK2 abolishes
this effect. This is the first demonstration of both a direct Raf-isoform-specific activation and a
regulatory role for CK2beta independent of the CK2alpha subunit. The present data thus link two
different protein kinases that were thought to work separately in the cell (Hagemann, 1997).
Timely deactivation of kinase cascades is crucial to the normal control of cell signaling and is partly
accomplished by protein phosphatase 2A (PP2A). The catalytic (alpha) subunit of the serine-threonine
kinase Casein kinaseII (CkII) binds to PP2A in vitro and in mitogen-starved cells; binding requires the
integrity of a sequence motif common to CK2alpha and SV40 small t antigen. Overexpression of
CK2alpha results in deactivation of mitogen-activated protein kinase kinase (MEK) and suppression
of cell growth. Moreover, CK2alpha inhibits the transforming activity of oncogenic Ras, but not that
of constitutively activated MEK. Thus, CK2alpha may regulate the deactivation of the
mitogen-activated protein kinase pathway (Heriche, 1997).
p53 is an essential component of cellular growth control. Some of its distinct biological functions are
regulated by interaction with cellular proteins.
p53 binds to the regulatory subunit of protein kinase CK2. Using C-terminal protein fragments of p53
it has been demonstrated that the region between amino acids 287 and 340 on the polypeptide chain of p53
is critical for the binding of p53 to the beta-subunit of CK2. Neither phosphorylation at the p34cdc2 site
(aa315) nor at the CK2 site (aa392) is necessary for binding of p53 to the beta-subunit of CK2. Using
deletion mutants of the CK2 beta-subunit, it has also been shown that an internal region between amino acids
72 and 149 of the CK2 beta-subunit is necessary for binding to p53. This study defines new
functional regions on the polypeptide chains of p53 and of protein kinase CK2 (Appel, 1995).
The protein p53 has been reported to catalyse the annealing of complementary DNA or RNA strands. This activity is inhibited in the presence of the serine/threonine protein kinase CK2. This inhibition can be explained by the occurrence
of a high-affinity molecular association between p53 and CK2. The molecular complex involves an interaction between the C-terminal domain of p53 and the beta subunit of the oligomeric kinase. Accordingly, the isolated alpha subunit of the kinase is without effect. In addition, after
phosphorylation by CK2, phosphorylated p53 loses its DNA annealing activity. Because the C-terminal
domain of p53 is both involved in the association with CK2 and phosphorylated by it, these results suggest
that either protein-protein interaction or phosphorylation of this domain might control the base pairing of
complementary sequences promoted by p53 in processes related to DNA replication and repair (Filhol, 1996).
p21WAF1/CIP1, which belongs to a class of regulatory proteins that interact with cyclin dependent kinases is a potent inhibitor of these kinases. The inhibition of the cyclin dependent kinases induces an arrest of cells in the G phase of the cell cycle. In addition p21WAF1/CIP1 associates with PCNA (Drosophila homolog: Mutagen-sensitive 209) and inhibits DNA replication. p21WAF1/CIP1 binds to the regulatory beta-subunit of protein kinase CK2 but not to the catalytic alpha-subunit. Binding of p21WAF1/CIP1 down regulates the kinase activity of CK2 with respect to the phosphorylation of the beta-subunit of CK2, casein and
the C-terminus of p53. This study demonstrates a new binding partner for the regulatory beta-subunit of protein kinase CK2 which regulates the activity of the holoenzyme (Gotz, 1996).
The oncogene product MDM2 can be phosphorylated by protein kinase CK2 in vitro. The catalytic subunit of protein kinase CK2 (alpha-subunit) catalyzes the incorporation of twice as much phosphate into the MDM2 protein as is obtained with the holoenzyme. Polylysine stimulates MDM2 phosphorylation by CK2 holoenzyme threefold in contrast to the alpha-subunit-catalyzed MDM2 phosphorylation which is reduced by about 66% when polylysine is added. Full length p53 mimics the polylysine effect in all respects; that is, stimulation of phosphate incorporation by CK2 holoenzyme and inhibition in the presence of the catalytic CK2 alpha-subunit. This is also the case with a peptide representing a C-terminal fragment of the tumor suppressor gene product p53 (amino acids 264-393, which also harbor the CK2beta interaction site at amino acids 287-340). Stimulation by p53(264-393) is on average close to twofold that of CkII, and inhibition in the case of the alpha-subunit-catalyzed MDM2 phosphorylation is about 40%.
Phosphorylation of MDM2 by CK2 holoenzyme in the presence of the p21(WAF1/CIP1), known to be a potent inhibitor of cyclin-dependent protein kinases, also leads to a significant reduction of phosphate incorporation into MDM2, indicating that p21(WAF1/CIP1) does not exclusively inhibit cell cycle
kinases. These data add new insight into the autoregulatory loop which include p21(WAF1/CIP1), MDM2 protein, CK2 and p53 (Guerra, 1997).
Phosphorylation of the p53 tumor suppressor protein is known to modulate its functions. Using bacterially produced glutathione S-transferase (GST)-p53 fusion protein and baculovirus-expressed histidine-tagged p53 [(His)p53], human p53 phosphorylation was determined by purified forms of
jun-N-kinase (JNK), protein kinase A (PKA), and the beta subunit of Casein kinase II (CkIIbeta) as well
as by kinases present in whole cell extracts (WCEs). PKA is potent p53 kinase, albeit, in a conformation- and concentration-dependent manner, as concluded by comparing full-length with truncated forms of p53. JNK interacts with p53, and JNK phosphorylates truncated forms of GST-p53 or full-length (His)p53. Dependence of phosphorylation on conformation of p53 is further supported by the finding that the wild-type form of p53 (p53wt) undergoes better phosphorylation by CKIIbeta and by WCE kinases than mutant forms of p53 at amino acid 249 [p53(249)] or 273 [p53(273)]. Moreover, shifting the kinase reaction's temperature from 37 degrees C to 18 degrees C reduces the phosphorylation of mutant p53 to a greater extent than of p53wt. A comparison of truncated forms of p53 reveals that the ability of CKIIbeta,
PKA, or WCE kinases to phosphorylate p53 requires amino acids 97-155 within the DNA-binding domain region. Among three 20-aa peptides spanning this region residues 97-117 increase p53 phosphorylation by CKIIbeta while inhibiting p53 phosphorylation by PKA or WCE kinases. The importance of this region is further supported by computer modeling studies, which demonstrate that mutant p53(249) exhibits significant changes within amino acids 97-117. In summary, phosphorylation-related analysis of different p53 forms in vitro indicates that conformation of p53 is a key determinant in its availability as a substrate for different kinases, and for the phosphorylation pattern generated by each kinase (Adler, 1997).
The catalytic subunit of Saccharomyces cerevisiae casein kinase II (Sc CKII) is encoded by the genes
CKA1 and CKA2, which together are essential for the animal's viability. Five independent
temperature-sensitive alleles of the CKA2 gene were isolated and used to analyze the function of CKII
during the cell cycle. Following a shift to the nonpermissive temperature, cka2ts strains arrest within
a single cell cycle and exhibit a dual arrest phenotype consisting of 50% unbudded and 50%
large-budded cells. The unbudded half of the arrested population contain a single nucleus and a
single focus of microtubule staining, consistent with arrest in G1. Most of the large-budded fraction
contain segregated chromatin and an extended spindle, indicative of arrest in anaphase, though a
fraction contained an undivided nucleus with a short thick intranuclear spindle, indicative of arrest in G2
and/or metaphase. Flow cytometry of pheromone-synchronized cells confirms that CKII is required in
G1, at a point that must lie at or beyond Start but prior to DNA synthesis. Similar analysis of
hydroxyurea-synchronized cells indicates that CKII is not required for completion of previously initiated
DNA replication but confirm that the enzyme is again required for cell cycle progression in G2
and/or mitosis. These results establish a role for CKII in regulation and/or execution of the eukaryotic
cell cycle (Hanna, 1995).
Casein kinase II (CKII) is a ubiquitous serine/threonine protein kinase with many cellular functions,
including participation in mitogenic signaling by cytoplasmic nuclear translocation. To examine
whether cell compartment-specific availability is a requirement for CKII function during cell cycle
progression, antibodies against CKII beta, the regulatory subunit of CKII, were microinjected into the
cytoplasm or the nucleus of G0-synchronized human primary fibroblasts (IMR-90) at the time of
mitogenic stimulation or at various intervals thereafter. Significant inhibition of the stimulation is
obtained with both cytoplasmic and nuclear injections. The inhibition is reversible, is not observed
with control antibodies, and is abolished by co-injection of purified CKII holoenzyme. The inhibition
differs, however, in extent, duration, and cell cycle phase between cytoplasmic and nuclear injections.
After cytoplasmic injection, inhibition reachs 45-50% and is effective at two intervals within the
first 2 h and at 12-16 h post-stimulation, i.e. at G0/G1 phase transition and at the G1/S phase boundary
of the cell cycle. After injection into the nucleus, the inhibition is considerably stronger, reaching
80-85%, and is effective for the first 6 h post-stimulation, i.e. for the transition of G0/G1 phase and
the adjoining first part of G1 phase. Cytoplasmic or nuclear injections within S phase affect neither
DNA synthesis nor cell division. The data suggest that cell cycle transition from G0 to S phase requires
the presence of a certain functional level of CKII at defined times and at defined cellular locations as
follows: for transition of G0/G1 at both the nucleus and the cytoplasm, for transition of early G1 at the
nucleus, and for transition of G1/S at the cytoplasm (Pepperkok, 1994).
BH3-only proapoptotic proteins of the Bcl-2 family such as Bad, Bid, Bim, or Bik transduce death stimuli from the cell surface to the central death machinery. Following apoptosis stimulation, these molecules translocate from the cytosol to mitochondria where they bind to membrane-based Bcl-2 family members. Bid plays an essential role in Fas-mediated apoptosis of the so-called type II cells.
In type II cells, such as Jurkat cells or hepatocytes, death-inducing signaling complex (DISC) formation is strongly reduced compared to type I cells in which
activation of large amounts of caspase 8 by the DISC enables direct activation of downstream caspases leading to irreversible cell damage. In type II cells, following cleavage by caspase 8, the C-terminal fragment of Bid translocates to mitochondria and triggers the release of apoptogenic factors, thereby inducing cell death. Bid is phosphorylated by casein kinase I (CKI) and casein kinase II (CKII). Inhibition of CKI and CKII accelerates Fas-mediated apoptosis and Bid cleavage, whereas hyperactivity of the kinases delays apoptosis. When phosphorylated, Bid is insensitive to caspase 8 cleavage in vitro. Moreover, a mutant of Bid that cannot be phosphorylated was found to be more toxic than wild-type Bid. Together, these data indicate that phosphorylation of Bid represents a new mechanism whereby cells control apoptosis (Desagher, 2001).
Kinase Suppressor of Ras (KSR) is a molecular scaffold that interacts with the core kinase components of the ERK cascade, Raf, MEK, and ERK and provides spatial and temporal regulation of Ras-dependent ERK cascade signaling. In this report, the heterotetrameric protein kinase, casein kinase 2 (CK2), has been identified as a new KSR1-binding partner. Moreover, the KSR1/CK2 interaction is required for KSR1 to maximally facilitate ERK cascade signaling and contributes to the regulation of Raf kinase activity. Binding of the CK2 holoenzyme is constitutive and requires the basic surface region of the KSR1 atypical C1 domain. Loss of CK2 binding does not alter the membrane translocation of KSR1 or its interaction with ERK cascade components; however, disruption of the KSR1/CK2 interaction or inhibition of CK2 activity significantly reduces the growth-factor-induced phosphorylation of C-Raf and B-Raf on the activating serine site in the negative-charge regulatory region (N-region). This decrease in Raf N-region phosphorylation further correlates with impaired Raf, MEK, and ERK activation. These findings identify CK2 as a novel component of the KSR1 scaffolding complex that facilitates ERK cascade signaling by functioning as a Raf family N-Region kinase (Ritt, 2006).
Carbon monoxide (CO) is a putative gaseous neurotransmitter that lacks vesicular storage and must be synthesized rapidly following neuronal depolarization. The biosynthetic enzyme for CO, heme oxygenase-2 (HO2), is activated during neuronal stimulation by phosphorylation by CK2 (formerly casein kinase 2). Phorbol ester treatment of hippocampal cultures results in the phosphorylation and activation of HO2 by CK2, implicating protein kinase C (PKC) in CK2 stimulation. Odorant treatment of olfactory receptor neurons augments HO2 phosphorylation and activity as well as cyclic guanosine monophosphate (cGMP) levels, with all of these effects selectively blocked by CK2 inhibitors. Likewise, CO-mediated nonadrenergic, noncholinergic (NANC) relaxation of the internal anal sphincter requires CK2 activity. These findings provide a molecular mechanism for the rapid neuronal activation of CO biosynthesis, as required for a gaseous neurotransmitter (Boehning, 2003).
Carbon monoxide is generated in neurons by the enzymatic cleavage of heme by heme oxygenase-2. Abundant evidence suggests that CO can function as a neurotransmitter. Like nitric oxide (NO), endogenously produced CO stimulates soluble guanylate cyclase (sGC) activity, increasing cGMP levels in target cells. HO2 and sGC expression overlap in many regions of the brain, including areas such as the olfactory bulb, which are devoid of the neuronal NO synthesizing enzyme nitric oxide synthase (nNOS). Olfactory receptor neurons (ORNs) generate micromolar quantities of CO, which are sufficient to activate endogenous sGC. Endogenously produced CO also regulates cGMP levels and odorant adaptation in olfactory receptor neurons of salamanders and invertebrates. Furthermore, HO inhibitors block odorant-induced cGMP production in rat ORNs (Boehning, 2003 and references therein).
The strongest evidence for a role of CO in neurotransmission comes from studies of nonadrenergic, noncholinergic (NANC) neurotransmission in the enteric nervous system. NANC transmission is substantially reduced by HO inhibitors and in mice with genomic deletion of HO2. Nitric oxide (NO) and CO appear to be coneurotransmitters in the gut; HO2 and neuronal NO synthase (nNOS) are both enriched in the myenteric neuronal plexus, and NANC neurotransmission, reduced in nNOS-deleted mice, is virtually abolished in mice with deletion of both HO2 and nNOS. Cyclic GMP levels are similarly reduced in intestinal preparations from nNOS and HO2 knockout mice (Boehning, 2003 and references therein).
Unlike conventional neurotransmitters, gases cannot be stored in synaptic vesicles. Therefore, release of NO or CO upon neuronal depolarization requires rapid activation of their biosynthetic enzymes. NO is generated by the calcium/calmodulin-dependent activation of nNOS during neuronal activity. Treatment of neuronal cultures with phorbol esters increases HO2 activity in a protein kinase C (PKC)-dependent manner. However, no direct molecular mechanism for depolarization-induced activation of HO2 during neuronal activity has been reported, which has led to skepticism about the physiologic role of CO as a neurotransmitter (Boehning, 2003 and references therein).
This study examines the molecular mechanisms by which neuronal depolarization leads to increased HO2 activity and subsequent CO synthesis. HO2 is regulated by a protein kinase cascade that ultimately leads to the direct phosphorylation and enzymatic activation of HO2 by the protein kinase CK2, resulting in CO-dependent neurotransmission. These results provide a mechanistic basis for the activation of CO biosynthesis following neuronal activity, as expected for a gaseous neurotransmitter/neuromodulator (Boehning, 2003).
Dorsal axis formation in Xenopus embryos is dependent upon asymmetrical localization of β-catenin, a transducer of the canonical Wnt signaling pathway. Recent biochemical experiments have implicated protein kinase CK2 as a regulator of members of the Wnt pathway including β-catenin. The role of CK2 in dorsal axis formation was examined. CK2 was present in the developing embryo at an appropriate time and place to participate in dorsal axis formation. Overexpression of mRNA encoding CK2 in ventral blastomeres was sufficient to induce a complete ectopic axis, mimicking Wnt signaling. A kinase-inactive mutant of CK2α was able to block ectopic axis formation induced by XWnt8 and β-catenin and was capable of suppressing endogenous axis formation when overexpressed dorsally. Taken together, these studies demonstrate that CK2 is a bona fide member of the Wnt pathway and has a critical role in the establishment of the dorsal embryonic axis (Dominguez, 2004).
In conclusion, experiments carried out in this study demonstrate that CK2 plays an essential role in the complex process of dorsal axis determination. The current model of dorsal axis formation proposes that in the fertilized embryo, β-catenin degradation is promoted by GSK3β phosphorylation. When the dorsal determinants move dorsally during cortical rotation, they promote signaling that stabilizes β-catenin. In cells in culture, β-catenin is regulated by a destruction complex that involves kinases, phosphatases, and scaffold proteins. In the Xenopus embryo, it is not know how β-catenin is dorsally up-regulated, since the nature of the dorsal determinants is still unknown. However, recent experiments have proposed that the dorsal determinants might include dsh and GBP, two Wnt transducers implicated in dorsal axis formation. These translocate to the dorsal side of the embryo where GSK3β is down-regulated, β-catenin accumulates, and dsh is phosphorylated. CK2, expressed most highly in the medial part of the embryo where β-catenin up-regulation occurs, may contribute to Wnt signaling by phosphorylating and stabilizing β-catenin itself, perhaps through the major CK2 phosphorylation site at T393 identified in mammalian cells. Alternatively, CK2 may act upon dsh, GBP, or other as yet uncharacterized dorsal determinants. Indeed, CK2 inhibition in mammalian cells leads to dsh instability (Dominguez, 2004).
The lack of CK2 expression in the vegetal part of the embryo is consistent with a model in which the constitutively active CK2 kinase does not act until the physical process of cortical rotation brings the dorsal determinants to the waiting enzyme in the medial portion of the embryo. This model is consistent with vegetal cortex transplantation studies that suggest that it is the combination of the dorsal determinants plus uncharacterized factors in the cytoplasm of the equatorial (medial) part of the embryo that are required for dorsal determination. Future experiments will validate this hypothesis through a more detailed analysis of the signaling pathway and of biochemical studies of functional protein complexes and their localization in the developing embryo (Dominguez, 2004).
Continued: Casein kinase II Evolutionary homologs part 2/2 | Home page: The Interactive Fly © 1995, 1996 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Casein kinase 2:
Biological Overview
| Regulation
| Developmental Biology
| Effects of Mutation
| References
Society for Developmental Biology's Web server.